Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s stock price traded down 13.2% during trading on Tuesday . The company traded as low as $1.4850 and last traded at $1.4850. 100 shares traded hands during trading, a decline of 96% from the average session volume of 2,473 shares. The stock had previously closed at $1.71.
Ascletis Pharma Price Performance
The stock has a fifty day moving average price of $1.58 and a two-hundred day moving average price of $1.46.
About Ascletis Pharma
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Featured Stories
- Five stocks we like better than Ascletis Pharma
- Wall Street Stockpicker Names #1 Stock of 2026
- Trump’s new AI budget just passed — one stock could soar
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Terrifying reason Trump killed the U.S. penny?
- Buy this $2 Gold Stock Before January 1, 2026
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
